Eli Lilly and Co. won more than 95.5 percent of the shares of New York-based ImClone Systems Inc. in a tender offer that ended at midnight yesterday. Lilly expects to complete its acquisition of ImClone on Monday. Indianapolis-based Lilly has agreed to pay $70 in cash for each share of ImClone, or $6.3 billion for […]
Eli Lilly and Co. has licensed the U.S. rights to commercialize its drug Cialis to treat high blood pressure in the pulmonary artery to United Therapeutics Corp., a Maryland-based biotech drug firm. Indianapolis-based Lilly will buy $150 million of United Therapeutics’ common stock, but also receive a $150 million upfront payment from United Therapeutics, according […]
Don Welsh is quickly making a name for himself as a change agent. Though few knew what to think when Welsh announced he was
leaving Seattle to become Indianapolis Convention & Visitors Association CEO, he’s shown he didn’t come here to simply
wind
down his career.
Indianapolis-based Eli Lilly and Co. said today that its workers and retirees contributed $11.1 million to the 2008 fundraising campaign of United Way of Central Indiana and other United Way chapters. The contribution includes a matching gift from Lilly Foundation. Lilly said it exceeded its goal by $100,000. The overall donation amounts to nearly 23 […]
CEOs with Simon Property, Duke Realty Corp. and Interactive Intelligence Inc. report that their companies are taking an uncharacteristically
cautious approach to acquisitions and investments, given the faltering economy.
Republican Gov. Mitch Daniels will be staying in the Statehouse for a second term. The Associated Press declared Daniels, a former Eli Lilly and Co. executive, the winner over Democrat Jill Long Thompson at 7:05 p.m. Thompson, a former U.S. representative from northern Indiana, was running close to Daniels as of this summer, but polls shows […]
Eli Lilly and Co. could face a delay on the highly anticipated weekly version of its diabetes drug, Byetta. Data for a once-weekly version of Byetta did not adequately show that batches of commercially manufactured Byetta were comparable with batches manufactured earlier for use in clinical trials. That’s what the U.S. Food and Drug Administration […]
Dr. Catherine Michael, a part-time emergency physician for Indianapolis-based St. Vincent Health, desperately wants Republican John McCain to be the next president. The 39-year-old mother of three gave McCain’s campaign $500 in May because, she said, he will appoint Supreme Court Justices that are antiabortion. Michael, who attends a conservative Presbyterian church, […]
Times are tough enough that more people are beginning to switch to generic drugs to save money. Insurers
like Indianapolis-based WellPoint are playing a role, too, by pushing policy holders toward generics.
People also are splitting pills…
A shareholder in New York-based ImClone Systems Inc. has filed a lawsuit in an attempt to stop its pending acquisition by Eli Lilly and Co., according to a disclosure filed today with the U.S. Securities and Exchange Commission. State-Boston Retirement System of Massachusetts and several individual ImClone shareholders claim the company provided too little information […]
Photos of four area university presidents graced the cover of The Indianapolis Star’s Sunday arts and entertainment section back in March. They were all female. My first reaction was, “Isn’t it cool that women are reaching the highest echelon of higher ed?” My second reaction was, “Why don’t any of them have gray hair?” Well, surely some of them do, since at that time their ages ranged from 59-66. It just doesn’t show. I was surprised. If there is a…
Republican Sen. John McCain has been unable to achieve the same Indiana fund-raising edge on his Democratic opponent that
President George W. Bush did in past elections. Bush rang up an Indiana fund-raising advantage of $1.7 million over Sen. John
Kerry in 2004, according to the Center for Responsive Politics. And his popularity in Indiana allowed
him to spend those dollars to help him campaign in other states while easily winning Indiana’s electoral
votes. But this election, Sen. Barack Obama had outraised Republican John McCain by $360,000 through the end of August, when
McCain’s decision to take public campaign funds forced him to stop raising funds directly for himself.
Obama did not take public funds, and so has continued to raise money.
Eli Lilly and Co.‘s settlement of Zyprexa litigation sent it to a $466 million loss during its third quarter. But the Indianapolis-based drugmaker exceeded expectations of Wall Street analysts. Lilly spent nearly $1.5 billion to settle a 32-state probe into its marketing and disclosures about Zyprexa, an antipsychotic that is the company’s bestselling drug. It […]
Uncertainty over when, or if, the U.S. Food and Drug Administration will approve prasugrel, a blood-thinner Eli Lilly and Co. hopes will be its next blockbuster, has taken a bite out of the company’s already slumping stock. Lilly shares closed Friday at $32.20, down $2.18, or 6.3 percent. It ticked up this morning, to $32.68, […]
A new clinic that is on the cusp of conducting human trials in Indianapolis could distinguish itself as a key player in drug development, not only within the state, but nationally as well. Centurion Clinical Research LLC serves pharmaceutical companies and medical-device makers that need to test their products before they can be approved for widespread use. That first phase, in which healthy people are paid to participate in the overnight studies, is critical in determining the safety and success…
Eli Lilly and Co. had been salivating over ImClone Systems Inc. for more than two years when, on July 25 of this year, its senior executives received a formal staff recommendation to contact the company and make an overture. So it must have come as quite a jolt to Lilly brass when, just six days later, Bristol-Myers Squibb announced that it was offering to buy the 83 percent of ImClone it didn’t already own for $60 a share, or $4.5…
A pharmaceutical industry publication says the U.S. Food and Drug Administration is convening a February meeting to discuss prasugrel, a blood-thinner Eli Lilly and Co. hopes will be its next blockbuster. The move likely would delay a decision on the new drug until March, according to The Pink Sheet, a weekly publication that covers regulatory […]
Eli Lilly and Co. has commenced its tender offer for New York-based ImClone Systems Inc., the Indianapolis-based drugmaker announced today. Lilly agreed on Oct. 6 to pay $70 a share in cash to acquire ImClone, for a total purchase price of $6.5 billion. Two of ImClone’s largest shareholders-ImClone Chairman Carl Icahn and New York-based Bristol-Myers […]
Eli Lilly and Co. has written a $6.5 billion IOU to acquire the cancer drugs of ImClone Systems Inc. Cancer drugs are now
the best-selling class of drugs in the world and one of the fastest growing.
Lilly looks forward with ImClone deal CEO Lechleiter taking bold steps It’s premature to pass judgment on Eli Lilly and Co.’s $6.5 billion plan to acquire biotech firm ImClone Systems Inc., but the giant deal is one more sign that relatively new CEO John Lechleiter isn’t afraid to make bold moves on Lilly’s behalf. The local drugmaker agreed Oct. 6 to pay $70 a share for New York-based ImClone, maker of blockbuster cancer drug Erbitux, outbidding an earlier offer of…
